Elite 50% OFF Act now – get top investing tools Register Now!

Mesoblast Limited

Contributing Author

Recent Articles by Mesoblast Limited

Nov-24	Mesoblast Trading Update at Annual General Meeting Highlights Continued Strong Growth in Ryoncil Revenue MESO GlobeNewswire
Nov-20	Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids MESO GlobeNewswire
Nov-17	James M. O'Brien Appointed Chief Financial Officer at Mesoblast MESO GlobeNewswire
Nov-04	Mesoblast to Meet With FDA Next Month to Discuss Rexlemestrocel-L and Opioid Cessation MESO GlobeNewswire
Oct-19	Ryoncil Net Revenues Increase 69% in Second Quarter Post Launch MESO GlobeNewswire
Oct-06	Ryoncil Revenues Increase 66% in Second Quarter Post Launch MESO GlobeNewswire
Oct-02	Ryoncil Receives J-Code From Medicare & Medicaid Services (CMS) Facilitating Reimbursement and Broader Patient Access MESO GlobeNewswire
Sep-26	Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs MESO GlobeNewswire
Sep-14	Successful Commercial Launch of Ryoncil Highlighted at Global Healthcare Conferences MESO GlobeNewswire
Sep-03	Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes MESO GlobeNewswire
Aug-28	Banner Year for Mesoblast With First FDA Product Approval and Successful Commercial Launch of Ryoncil MESO GlobeNewswire
Aug-27	Mesoblast Financial Results and Corporate Update Webcast MESO GlobeNewswire
Jul-17	Successful Commercial Launch of Ryoncil MESO GlobeNewswire
Jun-30	Mesoblast and FDA Align on Key Items for Revascor Biologic License Application in Ischemic Heart Failure MESO GlobeNewswire
Jun-11	Mesoblast Maintains Momentum With FDA on Accelerated Approval Pathway for Revascor in Ischemic Heart Failure and Label Extension for Ryoncil in Adults With GvHD MESO GlobeNewswire
May-14	FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil MESO GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.